Kura Oncology, Inc.
KURA
$10.86
$0.777.63%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 6.83% | 9.46% | -9.29% | -12.09% | -15.14% |
| Total Depreciation and Amortization | 3.94% | -11.91% | 145.73% | -26.79% | -7.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -0.56% | -24.33% | 9.70% | 101.05% | -14.04% |
| Change in Net Operating Assets | 89.41% | -110.92% | 1,284.31% | -148.71% | 262.35% |
| Cash from Operations | 27.14% | -173.21% | 245.45% | -180.18% | 59.99% |
| Capital Expenditure | -412.50% | 94.49% | 9.58% | -76.06% | -399.32% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 485.28% | 61.30% | -164.51% | 59.83% | 159.73% |
| Cash from Investing | 480.54% | 62.49% | -168.74% | 59.42% | 158.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 2,072.46% | -93.92% | -- | -100.00% | 260.14% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2,072.46% | -93.92% | -- | -100.00% | 260.14% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 128.32% | -304.45% | 303.42% | -56.52% | 117.71% |